Dr. Sunil Tulpule, MD

Dr. Tulpule practices at Banner Alzheimer's Institute in Sun City, Arizona.

Dr. Tulpule's NPI, 1366988024, was assigned on January 18, 2017. Dr. Tulpule holds Arizona license 64024.

Dr. Tulpule's primary practice is Banner Alzheimer's Institute, at 10515 W Santa Fe Dr, Sun City, AZ 85351 in Maricopa County. The practice phone is (602) 747-4000.

Dr. Tulpule's primary practice is Banner Alzheimer's Institute in Sun City, Arizona. Dr. Tulpule is also affiliated with Banner - University Medical Center Phoenix. The medical group on file is Banner Cancer Center Specialists LLC. Dmand AI also links Dr. Tulpule to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tulpule practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Tulpule's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Tulpule's licenses on file in 2 states: Arizona and Missouri.

CMS data shows 507 Medicare services from Dr. Tulpule across 9 procedure codes in 2024, for 175 Medicare patients. Medicare paid $41,175 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 175 Medicare patients who saw Dr. Tulpule in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tulpule's median patient age at 67, with 50% women.

In 2024, Dr. Tulpule wrote 1,036 Medicare Part D claims for 141 patients. 81% of them were for generic drugs. CMS names the drug for 784 of them, across 28 drugs with 11 or more claims each, at $2,368,011 in total drug cost. In 2023, CMS named 315 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Tulpule for performance year 2024, reported as part of a group. CMS lists Dr. Tulpule as offering telehealth.

Dmand AI links 17 papers to Dr. Tulpule, published from 2015 to 2022. 2015 was the busiest year, with 6. Dr. Tulpule has published most often in Clin Case Rep. Dr. Tulpule's most frequent co-authors are Shuvendu Sen, MD, Abdalla Mohamed Yousif, MD and Sabrina Khaleeq Arshed, MD.

CMS Open Payments shows 84 general payments to Dr. Tulpule from 22 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 47% of the total. ADC Therapeutics America, Inc. paid the most, $19,098.